Vivimed Labs gets approvals for 3 products from Hyderabad manufacturing site

17 Apr 2021

Vivimed Labs has received approvals for 3 products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site. The company has received approval for Bilastine tablets 20mg under brand name ‘FLUSTIN’, Ornidazole and Otloxacin tablets under brand name ‘ORZOLE COMBI’ and Paracetamol 125mg/5ml and Chlorpheniramine Maleate Syrup 2mg/5ml 100ml under brand name ‘FEBRIL’.

Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.

Related Vivimed Labs Ltd. Links:

Vivimed Labs Share Price

27.10 -1.00 (-3.56%) May 07, 18:03
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 679.50
Dr. Reddys Lab 5173.55
Lupin 1195.60
Piramal Enterprises 1670.45
Cadila Healthcare 603.10
View more..
Sensex vs Vivimed Labs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323